Bill Status of HJR 35   96th General Assembly


Short Description:  URGES-BIOSIMILAR DRUGS

House Sponsors
Rep. Maria Antonia Berrios

Last Action  View All Actions

DateChamber Action
  1/11/2011HouseSession Sine Die

Synopsis As Introduced
Urges the Congress of the United States to help ensure that any new legislation allowing for approval of biosimilar drugs includes provisions to ensure that the public health is protected by adequate testing of biosimilar products and physician control over which treatments their patients receive, and that the legislation preserves the ability to create innovative and important new biotechnology therapies.

Actions 
DateChamber Action
  3/10/2009HouseFiled with the Clerk by Rep. Maria Antonia Berrios
  3/11/2009HouseReferred to Rules Committee
  3/16/2009HouseAssigned to Bio-Technology Committee
  12/1/2009HouseRule 19(b) / Re-referred to Rules Committee
  1/11/2011HouseSession Sine Die

Back To Top